Claim your profile to get in front of buyers, investors, and analysts. Lyra Health - Crunchbase Company Profile & Funding It partners with enterprises, pharma companies, and health plans to create new products that help support and manage specific mental and physical conditions. LYRA HEALTH Revenue, Growth & Competitor Profile - IncFact.com The company has between 500 and 1000 employees and is backed by 20 investors. Company appoints Robynne Sisco to Board of Directors. After extensive research and analysis, Zippia's data science team found the following key financial metrics. The highwater mark was set pre-pandemic when the telepsychiatry and specialty pharmacy company Genoa Health sold to UnitedHealth Group for $2.5 billion in 2018. It was founded in 2010 and is based in Santa Monica, California. The next mental health startup to reach a billion dollar valuation was Calm in 2019. Lyra Health acquired 1 company. Lyra Health - Overview, News & Competitors | ZoomInfo.com Sisco is currently co-president and chief financial officer at Workday. Lyra Health Completes $235M Funding Round, led by Dragoneer, to Fuel Log In. Learn more. "2020 put the need for mental health care transformation in sharp focus, as more people sought help during these extraordinary and difficult times," said David Ebersman, Lyra Health CEO and co-founder. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. We heard from HR and benefits leaders, benefits consultants, and Lyra experts on top-of-mind issues for mental health in the workplace. BURLINGAME, Calif, Jan. 28, 2021 /PRNewswire/ --Lyra Health, the leading provider of comprehensive mental health care benefits for employers, today announced a Series E financing round of $187 million. These investors may include private investors, venture capital firms, or other investment vehicles. . This Series E round pushes the company to $475.1 million in total funding for a post money valuation of over $2 billion. Theres no slowdown in sight, with funding in the first quarter of 2021 topping $795 million as startups continue to jockey for post-pandemic market dominance. For more information, visit lyrahealth.com and follow us on LinkedIn, Facebook, and Twitter. Investor Activity Lyra Health has actively raised capital from investors. "As the demand for mental health care accelerates worldwide, I am honored to join them in the quest to deliver a powerful support system for companies and their employees. Mental wellness platform Lyra Health is raising up to - TechCrunch The mental health benefits startup scored $187 million in new financing as it looks to expand its services and bring more technology to its platform. About Dragoneer Investment GroupDragoneer is a growth-oriented investment firm with over $25 billion in long-duration capital. Environmental, Social and Governance (ESG), HVAC (Heating, Ventilation and Air-Conditioning), Machine Tools, Metalworking and Metallurgy, Aboriginal, First Nations & Native American, Lyra Health Study Finds Managers Struggling to Handle Employee Mental Health Concerns. our sites and services. Lyra Company Profile: Valuation & Investors | PitchBook The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. In April, KKR acquired a majority interest in the mental health electronic records software company Therapy Brands for an undisclosed amount. Lyra Health, a leading provider of innovative mental health benefits for more than 2.2 million global employees and dependents, is transforming mental health care by creating a frictionless experience for members, providers, and employers. Mental health issues are much more pervasive than is commonly known, and Lyra is thoughtfully redefining access to care by providing broad-based solutions through employers. Lyra Health, a provider of mental health benefits for employees, has raised $200 million in the latest funding round, bringing its total valuation to $4.6 billion. Zippia gives an in-depth look into the details of Lyra Health, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Lyra Health. Dragoneer led the round and was joined by new investor Salesforce Ventures along with existing investor Coatue. Note: Lyra Health's revenues are gauged from an analysis of company filings. 914-204-6412 Their latest was a Series . DEF 14A - sec.gov Lyra Health peak revenue was $9.3M in 2022. The Series F was led by Coatue and values the company at an astounding $4.6 billion. Comparatively, just 24% of people who receive care through traditional health plans demonstrate reliable clinical improvement. The biggest hurdle isn't treatmentit's access. Lyra's second annual Breakthrough conference was an enormous success, with over 2,000 registrants coming together to reimagine mental health. With the new funding, Lyra will accelerate its delivery of comprehensive, evidence-based, culturally responsive mental health care benefits for employees and their families around the world. Developer of a digital health platform designed to transform mental health care through technology along with the human touch. In her distinguished career, Sisco has held senior finance roles at VMware, VeriSign, and Oracle and she brings to Lyra more than 30 years of experience in corporate finance, accounting operations, investor relations, legal, and procurement. Before the pandemic, it was already estimated that less than half of adults and children living with mental health conditions in the U.S. went without any treatment. Lyra Health Expert Review, Pricing, Alternatives - 2023 Lyra Health Completes $200M Funding Round to Transform Mental Health The latest fundraising was led by investor hedge fund Coatue Management, with participation from new investor Sands Capital. "Providing high-quality mental health care for diverse employee populations around the world is one of the most critical and challenging issues for employers today. When typing in this field, a list of search results will appear and be automatically updated as you type. Based on Cognitive Behavioral Therapy principles, this immersive treatment model with ongoing support between sessions helps individuals improve faster. Lyra Therapeutics: Investor Contact: Argot Partners 212-600-1902 Lyra@argopartners.com Media Contact: Kathryn Morris 914-204-6412 kathryn@theyatesnetwork.com LianBio Investor Contact: Elizabeth . There's a lot more to emotions and connecting with people, reading people and diagnosing people than just looking at their face, says Gold, who is also a Forbes contributor. according to the National Alliance on Mental Illness. Lyra General Information. Lyra quickly connects members to an exclusive network of evidence-based providers, mental health coaches, digital wellness tools, and personalized medication programs. U.S. Industry Overview & Market Statistics: INDEPENDENT SCHOOL GROUP LIFE & DISABILITY TRUST, Complete list of funding rounds and total amounts in the, EBIT (Earnings Before Interest and Taxes), Revenue from previous years (2010 to present), Funding from Venture Capital and Private Equity firms, Additional industries in which the company operates, What is the company's size? Lyra delivers mental health for employees and family members at leading multinational companies, including eBay; Genentech, a member of the Roche Group; Uber; and VCA Animal Hospitals. In 2020, the company introduced Lyra Blended Care, which pairs video therapy sessions with personalized digital lessons and exercises based on Cognitive Behavioral Therapy (CBT) principles. San Francisco-based 6sense closed a $200 million Series E co-led by new investors Blue Owl and MSD Partners at a $5.2 billion valuation . Lyra Therapeutics, Inc. (Name of Registrant as Specified in its Charter) . Partnership opens expanded opportunity for LYR-210 to address chronic rhinosinusitis, a disease affecting approximately 88 million adults in China. About Lyra HealthLyra Health is the leading provider of Workforce Mental Health benefits, serving 10 million global employees and their dependents. Leading self-insured employers partner with Lyra to tailor value-driven mental health benefits programs specific to their workforce. Contact:Kaitlin Rebella[emailprotected] (248) 318-4303, Cision Distribution 888-776-0942 The firm's track record includes public and private investments across industries and geographies, with a particular focus on technology-enabled businesses. Industry: Health Care Services & Hospitals. tyler.gagnon@canalecomm.com, million adult CRS patients in China alone, we believe LYR-210 has the potential to address a significant unmet medical need and meaningfully improve the standard of care for patients in Asia., Internet Explorer presents a security risk. Lyra Health has 36 investors including Castlight Health, Providence, Castlight Health and Venrock Associates. LYR-210 is an anti-inflammatory, intra-nasal drug matrix in late-stage development that is designed to treat chronic rhinosinusitis (CRS), a debilitating inflammatory disease of the nasal passages. Any such forward-looking statements represent managements estimates as of the date of this press release. Series E - Lyra Health - 2021-01-28 - CrunchBase Her deep expertise in finance and operations at leading global organizations will be significant assets for Lyra as we work together to provide a single source for effective mental health care for the worlds greatest companies., Transforming Access to Mental Health Care Around the World. Funding. Lyra Health - Products, Competitors, Financials, Employees January 19, 2022 08:00 AM EDT, BURLINGAME, Calif. Lyra Health, the leading provider of innovative Workforce Mental Health solutions for employers, today announced it has completed a $235M financing. Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. Lyra's matching technology and innovative digital platform connect members to a curated network of top . For more information about Lyra Healths innovative mental health benefits for employers, visit lyrahealth.com. To ensure the most secure and best overall experience on our website, we recommend the latest versions of. ", "We are excited to welcome Robynne to our Board of Directors," said David Ebersman, Lyra Health CEO and co-founder. Lyra separately announced today it has acquired ICAS World, an employee assistance program provider with operations in more than 155 countries. Lyra Health's latest post-money valuation is from January 2022. BURLINGAME, Calif., June 14, 2021 /PRNewswire/ --Lyra Health, the leading provider of comprehensive mental health care benefits for employers, today announced it has completed a $200M financing. Many mental health providers choose to operate out of insurance networks, since the reimbursement rates are so low. Lyras lead product candidate, LYR-210, is in late-stage clinical development for the treatment of chronic rhinosinusitis and is designed to deliver up to six months of continuous anti-inflammatory drug therapy to the sinonasal passages. from 8 AM - 9 PM ET. Pricing. Dragoneer has a history of partnering with management teams growing exceptional companies characterized by sustainable differentiation and superior economic models. Lyra Health Investors. Lyra Health has raised a total of $910.1M in funding over 8 rounds. Lyra Health revenue is $9.3M annually. and other contracted partners to be your Lyra Care Navigator Team and deliver clinical services. LianBio will be responsible for the clinical development and commercialization of LYR-210 in the licensed territories, and Lyra will retain all rights to LYR-210 in all other geographies. Spring Health provides personalized mental healthcare for employees' well-being. Lyra Health is a leading provider of innovative mental health benefits for more than 2.5 million global employees and dependents and is transforming mental health care by . Jessi Gold, a psychiatrist and assistant professor at Washington University in St. Louis, has been conducting virtual appointments but prefers to see patients in person. Modern Health operates as a mental health benefits platform for employers. It also noted that Lyra Health's most recent price per share is $27.47, an up round from the Series D, which priced shares at $14.21. Coatue Management, Dragoneer Investment Group, and Salesforce Ventures, Coatue Management, Institutional Venture Partners, Sands Capital, and Undisclosed Investors, Addition, Baillie Gifford & Co., Durable Capital Partners, Fidelity Investments, Institutional Venture Partners, Sands Capital, and Undisclosed Investors. Theres also concern that the hyper focus on technology and virtual care is like putting lipstick on a pig. But venture capital-backed technology startups alone wont solve the complicated morass of weak insurance coverage, crazy administrative hoops for patients in distress and clinicians burned out from carrying the weight of Americas pain. Some of these valuations are beyond appropriate given the underlying fundamentals, Suennen says. Get the full list, Youre viewing 5 of 35 investors. Coatue led the round and was joined by new investor Sands Capital, along with existing investors. Lyra Health Completes $200M Funding Round | Lyra Health But it was the Covid-19 pandemic and collective psychological fallout that finally mainstreamed mental health. Lyra also continues to pioneer new evidence-based, technology-enabled mental health solutions that accelerate access to care and match members to clinically proven programs that prioritize fast and durable symptom improvement. Behavioral Unicorn Lyra Health Eyes More Corporate Customers, Continued You can't just put a tool in an inequitable system and expect it to solve all of those inequities, says Nicole Martinez-Martin, an assistant professor at the Stanford Center for Biomedical Ethics who studies mental health apps. Lyra Therapeutics and LianBio Announce Strategic Partnership and Lyra Health Revenue: Annual, Quarterly, and Historic - Zippia Dr. . The company was formerly known as Happify Health and Happify. When typing in this field, a list of search results will appear and be automatically updated as you type. Lyra Health has a post-money valuation in the range of $1B to $10B as of Jan 19, 2022 . This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Lyras curated network includes more than 5,000 coaches, therapists, and doctors in the U.S., with an additional 85,000 providers available worldwide through global partnerships. Phone Number +1 877 0505 7147. PitchBooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach. Constrained optimization for provider groups, Personalized adaptive risk assessment service, Co-Founder, Chief Executive Officer & Board Member, To view Lyras complete valuation and funding history, request access, To view Lyras complete cap table history, request access, Youre viewing 2 of 29 competitors. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause the companys actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the following: the fact that the company has incurred significant losses since inception and expects to incur losses for the foreseeable future; the companys need for additional funding, which may not be available; the companys limited operating history; the fact that the company has no approved products; the fact that the companys product candidates are in various stages of development; the fact that the company may not be successful in its efforts to identify and successfully commercialize its product candidates; the fact that clinical trials required for the companys product candidates are expensive and time-consuming, and their outcome is uncertain; the fact that the FDA may not conclude that certain of the companys product candidates satisfy the requirements for the Section 505(b)(2) regulatory approval pathway; the companys inability to obtain required regulatory approvals; effects of recently enacted and future legislation; the possibility of system failures or security breaches; effects of significant competition; the fact that the successful commercialization of the companys product candidates will depend in part on the extent to which governmental authorities and health insurers establish coverage, adequate reimbursement levels and pricing policies; failure to achieve market acceptance; product liability lawsuits; the fact that the company relies on third parties for the manufacture of materials for its research programs, pre-clinical studies and clinical trials; the companys reliance on third parties to conduct its preclinical studies and clinical trials; the companys inability to succeed in establishing and maintaining collaborative relationships; the companys reliance on certain suppliers critical to its production; failure to obtain and maintain or adequately protect the companys intellectual property rights; failure to retain key personnel or to recruit qualified personnel; difficulties in managing the companys growth; effects of natural disasters; the fact that the global pandemic caused by COVID-19 could adversely impact the companys business and operations, including the companys clinical trials; the fact that the price of the companys common stock may be volatile and fluctuate substantially; significant costs and required management time as a result of operating as a public company and any securities class action litigation.